Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

UBS starts coverage of Inchcape at 'buy'

(Sharecast News) - UBS initiated coverage of Inchcape on Thursday with a 'buy' rating and 920p price target, saying it sees 40% upside potential. The bank said car dealership Inchcape has a strong, intact, value proposition for automotive OEMs, with a diversified country and brand portfolio that offers "resilience in challenging conditions".

UBS said its unique new dataset shows that volumes have steadily outperformed end-markets over the long term, and in the short term look on track to deliver a required reacceleration in the second half of 2025.

"Despite challenging auto markets, we expect Inchcape to achieve steady market-share gains, stable margins and strong cash conversion - which results in a forecast +5% FY'25-29 estimated profit compound annual growth rate and a sustainable circa 10% cash return per annum," UBS said.

"However, 12 months of de-rating has left Inchcape on less than 8x price-to-earnings, pricing in ongoing earnings declines."

At 1240 BST, the shares were up 4.2% at 690.50p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.